Title: Tasimelteon: a selective and unique receptor binding profile.
Journal: Neuropharmacology 20150401
Title: Tasimelteon for the treatment of non-24-hour sleep-wake disorder.
Journal: Drugs of today (Barcelona, Spain : 1998) 20150101
Title: Mechanism of action of tasimelteon in non-24 sleep-wake syndrome: treatment for a circadian rhythm disorder in blind patients.
Journal: CNS spectrums 20141201
Title: Cardiovascular effects of melatonin receptor agonists.
Journal: Expert opinion on investigational drugs 20121101
Title: Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system.
Journal: Central nervous system agents in medicinal chemistry 20120901
Title: Circadian and wakefulness-sleep modulation of cognition in humans.
Journal: Frontiers in molecular neuroscience 20120101
Title: cGMP-phosphodiesterase inhibition enhances photic responses and synchronization of the biological circadian clock in rodents.
Journal: PloS one 20120101
Title: Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction.
Journal: TheScientificWorldJournal 20120101
Title: Recent progress in the development of agonists and antagonists for melatonin receptors.
Journal: Current medicinal chemistry 20120101
Title: Melatonin receptor agonists: new options for insomnia and depression treatment.
Journal: CNS neuroscience & therapeutics 20111201
Title: Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.
Journal: Therapeutic advances in neurological disorders 20110901
Title: Tasimelteon for insomnia.
Journal: Expert opinion on investigational drugs 20110701
Title: Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20110601
Title: Neurochemical and neuropharmacological aspects of circadian disruptions: an introduction to asynchronization.
Journal: Current neuropharmacology 20110601
Title: Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications.
Journal: Neuroendocrinology 20110101
Title: Disrupted chronobiology of sleep and cytoprotection in obesity: possible therapeutic value of melatonin.
Journal: Neuro endocrinology letters 20110101
Title: Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs.
Journal: Advances in therapy 20101101
Title: [The newer sedative-hypnotics].
Journal: Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20100901
Title: A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.
Journal: Current neuropharmacology 20100901
Title: Investigational melatonin receptor agonists.
Journal: Expert opinion on investigational drugs 20100601
Title: Melatonin agonists and insomnia.
Journal: Expert review of neurotherapeutics 20100201
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20100101
Title: Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
Journal: Current opinion in investigational drugs (London, England : 2000) 20090701
Title: Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat.
Journal: Neuroscience letters 20090626
Title: New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists.
Journal: Neuropsychiatric disease and treatment 20090101
Title: Melatonin and its agonists: an update.
Journal: The British journal of psychiatry : the journal of mental science 20081001
Title: Analysis of low level radioactive metabolites in biological fluids using high-performance liquid chromatography with microplate scintillation counting: method validation and application.
Journal: Journal of pharmaceutical and biomedical analysis 20050901
Title: Preclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonist.
Journal: Journal of pharmaceutical sciences 20030401
Title: Christian Lavedan, et al. Tasimelteon: a selective and unique receptor binding profile. Neuropharmacology. 2015 Apr;91:142-7.
Title: Keating GM, et al. Tasimelteon: A Review in Non-24-Hour Sleep-Wake Disorder in Totally Blind Individuals. CNS Drugs. 2016 Mar 22.
